RAD001 and zoledronic acid in patients with renal cell carcinoma with bone metastases (RAZOR): A randomized phase II trial

Category Primary study
JournalJournal of Clinical Oncology
Year 2013
This article has no abstract
Epistemonikos ID: 23284e782a327e9c93ec88fad51e6eb74dacc4c2
First added on: Feb 05, 2025